维普中文期刊产品整合服务
104篇 您的检索式:作者名="Heerspink"
    题名 作者 年代 出处 被引量
1Alkalinization of urine samples preserves albumin concentrations during prolonged frozen stor- age in patients with diabetes mellitus 显示文摘Lambers Heerspink H J Nauta FL van der Zee CP 2009Diabet Med2009,26,5:1
2Effect of lowering blood pressure on cardiovascular events and mor tal i ty in patients on dialysis:A systematic review and meta-analysis of randomised controlled trials显示文摘Heerspink HJ Ninomiya T Zoungas S 0,,9668:1
3Visit-to-Visit Variability in Blood Pressure and Kidney and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Nephropathy: A Post Hoc Analysis From the RENAAL Study and the Irbesartan Diabetic Nephropathy Trial显示文摘Ciaran J. McMullan Hiddo J. Lambers Heerspink Hans-Henrik Parving Jamie P. Dwyer John P. Forman Dick de Zeeuw 2014American Journal of Kidney Diseases2014,,5:1
4Renal and cardio-protective effects of direct renin inhibition: a systematic literature review显示文摘Lambers Heerspink HJ Perkovic V de Zeeuw D 2009J Hypertens2009,27,12:1
5Kyphoplasty as treatment for osteoporotic vertebral compression fractures:relatively safe,but still no evidence of functi onal improvement;a review of the literature显示文摘Sietsma M S Heerspink F O Ploeg W T 2008Ned Tijdschr Geneeskd2008,152,:1
6Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials显示文摘Hiddo J Lambers Heerspink Toshiharu Ninomiya Sophia Zoungas Dick de Zeeuw Diederick E Grobbee Meg J Jardine Martin Gallagher Matthew A Roberts Alan Cass Bruce Neal Vlado Perkovic 20092009 (9668)2009,,9668:1
7Intensive glucose control improves kidney outcomes in patients with type 2 diabetes显示文摘Perkovic V Heerspink HL Chalmers J 0,,03:1
8Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial显示文摘Yan Miao Stefan A. Ottenbros Goos D. Laverman Barry M. Brenner Mark E. Cooper Hans-Henrik Parving Diederick E. Grobbee Shahnaz Shahinfar Dick de Zeeuw Hiddo J. Lambers Heerspink 2011Hypertension2011,,1:1
9Is doubling of serum creatinine a valid clinical ' hard' endpoint in clinical nephrology trials 显示文摘Lambers Heerspink HJ Perkovic V de Zeeuw D 2011Nephron Clin Pract2011,119,3:1
10Intensive glucose control improves kidney outcomes in patients with type 2 diabetes显示文摘Perkovic V Heerspink HL Chalmers J 0,,03:1
11Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria显示文摘Heerspink HL Greene T Lewis JB 2008Nephrol Dial Transplant2008,23,6:1
12First morn- ing voids are more reliable than spot urine samples to assess mi croalbuminuria显示文摘Witte EC Lambers Heerspink HJ de Zeeuw D 2009J Am Soc Nephrol2009,20,43:1
13The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events:results from the ONTARGET trial显示文摘Heerspink H J Gao P de Zeeuw D 2014Eur J Prey Cardiol2014,21,3:1
14First morn- ing voids are more reliable than spot urine samples to assess mi croalbuminuria显示文摘Witte EC Lambers Heerspink HJ de Zeeuw D 2009J Am Soe Nephrol2009,20,2:1
15Intensive glucose control improves kidney outcomes in patients with type 2 diabetes显示文摘Perkovic V Heerspink H L Chalmers J 2013Kidney international2013,83,3:1
16Comparison of different measures of urinary protein excretion for prediction of renal events显示文摘Lambers Heerspink HJ Gansevoort RT Brenner BM 0,,08:1
17Intensive glucose control improves kidney outcomes in patients with type 2 diabetes显示文摘Perkovic V Heerspink HL Chalmers J 2013Kidney Int2013,83,3:1
18The selective vitamin D receptor activator for albuminuria lowering (VITAL) study:study design and baseline characteristics显示文摘Lambers Heerspink HJ Agarwal R Coyne DW 2009Am J Nephrol2009,30,3:1
19Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes显示文摘Lambers Heerspink HJ de Zeeuw D Wie L 2013Diabetes Obes Metab2013,15,9:1
20Rationale for and study design of the sulodexide trials in type 2 diabetic,hypertensive patients with urinary albumin excretion rate or overt nephropathy显示文摘Lambers Heerspink HJ Fowler MJ Volgi J 2007Diabet Med2007,24,11:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费